About Us

Leveraging our streamlined operations from R & D to manufacturing, we have crafted a value-add model that effectively transitions from APIs to various formulations and new drug delivery systems.

Our outstanding 7 manufacturing facilities, stringent quality standards, robust compliance practices and an enviable regulatory track record combine to make our Finished Dosage business, a true value-based solution. Be it sterile, solid dosage forms or specialist filling, we accelerate the speed-to-market for our customers while mitigating risk.
We have initiated several strategic initiatives to strengthen and fortify our FDF business across generic, branded and contract manufacturing segments.

In a short span we expanded our MRs from 40 to a 100, achieved 30 market authorizations and ANDA’s and have set-up a contract research lab to support our own filings of MA and ANDA.

Having established ourselves with finished formulations in the semi regulated markets, we set our sights on growth in the regulated generic markets such as Europe, US, Canada & Australia.

Regulated Market

With the acquisition of the US FDA inspected solid oral dosage (SOD) facility at Alathur, Tamilnadu, from Actavis in 2013, we are now ready to deliver quality generic formulations to the regulated market. Our facility at Alathur, Tamilnadu, India is dedicated to solid dosage form manufacturing, supported by an outstanding regulatory record and intimate knowledge of regulations. We cover everything from blending, granulation, compression, encapsulation, coating, drying and formulation to packaging.

Manufacturing Facility

Located on an expansive area of 20,000 sq. Mts, this facility is equipped with state-of- art machinery. With a current installed capacity of 1.2billion Solid Oral Dosage (SOD) (Capsules 500 Milo Units; Tablets: 700 Milo Units), plans are underway to enhance this capacity to 2 billion SOD.

In conformance with CGMP, USFDA, EUGMP, WHOGMP and other technical and statutory requirements.

Installed with the latest HVAC / water systems and are equipped with high speed automated lines ensuring quality & time delivery of products.

Can handle 12 product transfers per year

Packaging capacity : 300 Milo Units

Warehouse equipped with

1099 pallets space for RM and PM

80 pallet space for FP

Dedicated mfg. areas for product transfers & commercials

100% check weigher for filled capsules

Tablet press with auto-weight control

Integrated bottle packaging line with tertiary 1D barcode

Semi – Regulated Market (RoW)

Our capabilities to meet the regulatory requirements of different countries, has enabled us to develop a rich and diverse product portfolio of branded formulations in ophthalmic, nutraceutical & dermatology. Thus, we ensure that we meet customers’ requirements in India, Southeast Asia, Africa and Middle East.

We are making a conscious effort to expand our global footprint by having alliances with global players for collaborative research, marketing tie-ups and joint ventures to create synergies.

Our 5 manufacturing facilities all of which are WHO and CGMP certified, are equipped to deliver a range of dosage delivery formats that include Capsules, Tablets, Syrups & liquids, Sprays & ointments, making us the preferred manufacturing partner for global pharmaceutical organizations.